Your browser doesn't support javascript.
loading
Defining Success in Open Science [version 2; peer review:2 approved].
Ali-Khan, Sarah E; Jean, Antoine; MacDonald, Emily; Gold, E Richard.
Affiliation
  • Ali-Khan SE; Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.
  • Jean A; Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, McGill University, 3801 University, Montreal, H3A 2B4, Canada.
  • MacDonald E; Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.
  • Gold ER; Faculty of Law, Centre for Intellectual Property Policy (CIPP), McGill University, 3644 Rue Peel, Montreal, H3A 1W9, Canada.
MNI Open Res ; 2: 2, 2018.
Article in En | MEDLINE | ID: mdl-33937622
ABSTRACT
Mounting evidence indicates that worldwide, innovation systems are increasing unsustainable. Equally, concerns about inequities in the science and innovation process, and in access to its benefits, continue. Against a backdrop of growing health, economic and scientific challenges global stakeholders are urgently seeking to spur innovation and maximize the just distribution of benefits for all. Open Science collaboration (OS) - comprising a variety of approaches to increase open, public, and rapid mobilization of scientific knowledge - is seen to be one of the most promising ways forward. Yet, many decision-makers hesitate to construct policy to support the adoption and implementation of OS without access to substantive, clear and reliable evidence. In October 2017, international thought-leaders gathered at an Open Science Leadership Forum in the Washington DC offices of the Bill and Melinda Gates Foundation to share their views on what successful Open Science looks like. Delegates from developed and developing nations, national governments, science agencies and funding bodies, philanthropy, researchers, patient organizations and the biotechnology, pharma and artificial intelligence (AI) industries discussed the outcomes that would rally them to invest in OS, as well as wider issues of policy and implementation. This first of two reports, summarizes delegates' views on what they believe OS will deliver in terms of research, innovation and social impact in the life sciences. Through open and collaborative process over the next months, we will translate these success outcomes into a toolkit of quantitative and qualitative indicators to assess when, where and how open science collaborations best advance research, innovation and social benefit. Ultimately, this work aims to develop and openly share tools to allow stakeholders to evaluate and re-invent their innovation ecosystems, to maximize value for the global public and patients, and address long-standing questions about the mechanics of innovation.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Qualitative_research Language: En Journal: MNI Open Res Year: 2018 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Qualitative_research Language: En Journal: MNI Open Res Year: 2018 Document type: Article Affiliation country: Canada